Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Betts

Showing results (121-130 of 150) with videos related to

Pageof 15
Sort By:
Blood Advances|January 27, 2026
Targeting Aurora Kinase A to Prevent GVHD and Relapse after Myeloablative Allogeneic Hematopoietic Cell TransplantationShernan G Holtan, Punita Grover, Kelly Walton, et al.
Bone Marrow Transplantation|January 9, 2021
Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplantGrigori Okoev, Daniel J Weisdorf, John E Wagner, et al.
Transplantation and Cellular Therapy|December 15, 2025
HIGHER HLA-DRB1 EVOLUTIONARY DIVERGENCE (HED) IS ASSOCIATED WITH REDUCED RELAPSE AND IMPROVED SURVIVAL AFTER MATCHED UNRELATED HEMATOPOIETIC CELL TRANSPLANTATIONJennifer N Saultz, Yung-Tsi Bolon, Tao Wang, et al.
Cancer|April 27, 2024
Psychological distress and mental health care utilization among Black survivors of adolescent and young adult cancerEunju Choi, Amy M Berkman, Aryce Battle, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in GVHD Risk Without Increased Relapse Risk Compared to Historical Cyclosporine/MethotrexateNajla El Jurdi, Alex Hoover, Daniel O'Leary, et al.
Haematologica|June 13, 2012
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantationJoseph Pidala, Jongphil Kim, Heather Jim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 12, 2024
Psychological distress and mental health care utilization among lesbian, gay, and bisexual survivors of adolescent and young adult cancerEunju Choi, Amy M Berkman, Clark R Andersen, et al.
Journal of Adolescent and Young Adult Oncology|July 25, 2025
Cancer Screening Uptake and Usual Source of Care Among Hispanic Survivors of Adolescent and Young Adult CancerEunju Choi, Amy M Berkman, Clark R Andersen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2018
Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiationBrian C Betts, David Bastian, Supinya Iamsawat, et al.
Psycho-Oncology|November 13, 2023
Psychological distress and mental health care utilization among Hispanic/Latino survivors of adolescent and young adult cancerEunju Choi, Amy M Berkman, Christabel K Cheung, et al.
Pageof 15

Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
Blood Advances|January 27, 2026
Targeting Aurora Kinase A to Prevent GVHD and Relapse after Myeloablative Allogeneic Hematopoietic Cell TransplantationShernan G Holtan, Punita Grover, Kelly Walton, et al.
Bone Marrow Transplantation|January 9, 2021
Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplantGrigori Okoev, Daniel J Weisdorf, John E Wagner, et al.
Transplantation and Cellular Therapy|December 15, 2025
HIGHER HLA-DRB1 EVOLUTIONARY DIVERGENCE (HED) IS ASSOCIATED WITH REDUCED RELAPSE AND IMPROVED SURVIVAL AFTER MATCHED UNRELATED HEMATOPOIETIC CELL TRANSPLANTATIONJennifer N Saultz, Yung-Tsi Bolon, Tao Wang, et al.
Cancer|April 27, 2024
Psychological distress and mental health care utilization among Black survivors of adolescent and young adult cancerEunju Choi, Amy M Berkman, Aryce Battle, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in GVHD Risk Without Increased Relapse Risk Compared to Historical Cyclosporine/MethotrexateNajla El Jurdi, Alex Hoover, Daniel O'Leary, et al.
Haematologica|June 13, 2012
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantationJoseph Pidala, Jongphil Kim, Heather Jim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 12, 2024
Psychological distress and mental health care utilization among lesbian, gay, and bisexual survivors of adolescent and young adult cancerEunju Choi, Amy M Berkman, Clark R Andersen, et al.
Journal of Adolescent and Young Adult Oncology|July 25, 2025
Cancer Screening Uptake and Usual Source of Care Among Hispanic Survivors of Adolescent and Young Adult CancerEunju Choi, Amy M Berkman, Clark R Andersen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2018
Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiationBrian C Betts, David Bastian, Supinya Iamsawat, et al.
Psycho-Oncology|November 13, 2023
Psychological distress and mental health care utilization among Hispanic/Latino survivors of adolescent and young adult cancerEunju Choi, Amy M Berkman, Christabel K Cheung, et al.
Pageof 15